“Lipoprotein(a) As an Unmodifiable Risk Marker in a Modifiable Risk World: Testing, Interpretation and Communication”. Journal of Heart and Cardiovascular Science, vol. 2, no. 1, Nov. 2021, pp. 14-19, https://doi.org/10.5281/zenodo.22305492.